[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[2] |
Slaney G. Results of treatment of carcinoma of the colon and rectum[J]. Mod Trends Surg, 1971, 3(4):69-89.
|
[3] |
Heald R J, Ryall R D. Recurrence and survival after total mesorectal excision for rectal cancer[J]. Lancet, 1986, 1(8496):1479-1482.
|
[4] |
Jeong SY, Ji WP, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial[J]. Lancet Oncology, 2014, 15(7):767-774.
|
[5] |
Laurent C, Leblanc F, Wutrich P, et al. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results[J]. Annals of Surgery, 2009, 250(1):54-61.
|
[6] |
Veldkamp R, Kuhry E, Hop WC, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial[J]. Lancet Oncology, 2005, 6(7):477-484.
|
[7] |
Berends FJ, Kazemier G, Bonjer HJ, et al. Subcutaneous metastases after laparoscopic colectomy[J]. Lancet, 1994, 344(8914):58-66.
|
[8] |
Cirocco WC, Schwartzman A, Golub RW. Abdominal wall recurrence after laparoscopic colectomy for colon cancer[J]. Surgery, 1994, 116(5):842-846.
|
[9] |
Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer[J]. Br J Surg, 2013, 100(1):75-82.
|
[10] |
Huscher CG, Bretagnol F, Corcione F. Laparoscopic Colorectal Cancer Resection in High-Volume Surgical Centers: Long-Term Outcomes from the LAPCOLON Group Trial[J]. World J Surg, 2015, 39(8):2045-2051.
|
[11] |
Schiphorst AH, Verweij NM, Pronk A, et al. Non-surgical complications after laparoscopic and open surgery for colorectal cancer - A systematic review of randomised controlled trials[J]. Eur J Surg Oncol, 2015, 41(9):1118-1127.
|
[12] |
Cecil TD, Sexton R, Moran BJ, et al. Total Mesorectal Excision Results in Low Local Recurrence Rates in Lymph Node-Positive Rectal Cancer[J]. Diseases of the Colon & Rectum, 2004, 47(7):1145-1150.
|
[13] |
Faerden AE, Naimy N, Wiik P, et al. Total mesorectal excision for rectal cancer: difference in outcome for low and high rectal cancer[J]. Diseases of the Colon & Rectum, 2005, 48(12):2224-2231.
|
[14] |
Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer[J]. Br J Surg, 2002, 89(3):327-334.
|
[15] |
Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit[J]. Am J Surg Pathol, 2002, 26(3):350-357.
|
[16] |
Glynne-Jones R, Mawdsley S, Novell JR. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language[J]. Colorectal Dis, 2006, 8(9):800-807.
|
[17] |
Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer[J]. Arch Pathol Lab Med, 2006, 130(3):318-324.
|
[18] |
Nagtegaal ID, Cj VDV, Van DWE, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2002, 20(7):1729-1734.
|
[19] |
Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?[J]. Annals of Surgery, 1996, 224(5):647-664.
|
[20] |
Veenhof AA FA, Sietses C, Blomberg BMEV, et al. The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial[J]. International Journal of Colorectal Disease, 2011, 26(1):53-59.
|
[21] |
Allendorf JD, Bessler M, Whelan RL, et al. Postoperative immune function varies inversely with the degree of surgical trauma in a murine model[J]. Surgical Endoscopy, 1997, 11(5):427-430.
|
[22] |
Veenhof AAFA, Sietses C, Blomberg BMEV, et al. The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial[J]. International Journal of Colorectal Disease, 2011, 26(1):53-61.
|
[23] |
Pascual M, Salvans S, Pera M. Laparoscopic colorectal surgery: current status andimplementation of the latest technological innovations[J]. World Journal of Gastroenterology, 2016, 22(2):704-717.
|
[24] |
Liu C, Liu J, Zhang S. Laparoscopic versus conventional open surgery for immune function in patients with colorectal cancer[J]. International Journal of Colorectal Disease, 2011, 26(11):1375-1385.
|
[25] |
Arezzo A, Passera R, Scozzari G, et al. Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and meta-analysis[J]. International Journal of Colorectal Disease, 2015, 30(11):1457-1472.
|
[26] |
Yamamoto S, Fujita S, Ishiguro S, et al. Wound infection after a laparoscopic resection for colorectal cancer[J]. Surgery Today, 2008, 38(7):618-622.
|
[27] |
Fleshman J, Branda M, Sargent DJ, et al. Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial[J]. Jama, 2015, 314(13):1346-1351.
|
[28] |
Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial[J]. Jama the Journal of the American Medical Association, 2015, 314(13):1356-1360.
|
[29] |
Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial[J]. Lancet, 2005, 365(9472):1718-1722.
|
[30] |
Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer[J]. British Journal of Surgery, 2009, 96(12):1493-1494.
|
[31] |
Pas MHVD, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial[J]. Lancet Oncology, 2013, 14(3):210-218.
|
[32] |
Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer[J]. New England Journal of Medicine, 2015, 372(14):1324-1330.
|